| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 | 
|---|---|---|---|---|
Growth matrix (%)  | ||||
Revenue growth  | 19.27  | -4.78  | -27.76  | -1.93  | 
Op profit growth  | -573.01  | -152.92  | 6,404.37  | -85.7  | 
EBIT growth  | -140.11  | 166.96  | 141.35  | 25.54  | 
Net profit growth  | -135.56  | -1,091.04  | -88.62  | 210.8  | 
Profitability ratios (%)  | ||||
OPM  | 9.22  | -2.32  | 4.18  | 0.04  | 
EBIT margin  | 2.19  | -6.53  | -2.33  | -0.69  | 
Net profit margin  | -7.55  | 25.33  | -2.43  | -15.45  | 
RoCE  | 1.05  | -2.58  | -0.93  | -0.35  | 
RoNW  | -1.68  | 5.67  | -0.62  | -4.91  | 
RoA  | -0.9  | 2.5  | -0.24  | -1.97  | 
Per share ratios (₹)  | ||||
EPS  | -19.38  | 62.16  | -3.92  | 0  | 
Dividend per share  | 0  | 0  | 0  | 0  | 
Cash EPS  | -34.08  | 39.71  | -26.49  | -68.5  | 
Book value per share  | 267.18  | 304.81  | 241.26  | 257.8  | 
Valuation ratios  | ||||
P/E  | -13.61  | 6.14  | -40.6  | 0  | 
P/CEPS  | -7.73  | 9.61  | -6  | -9.77  | 
P/B  | 0.98  | 1.25  | 0.65  | 2.59  | 
EV/EBIDTA  | 17.58  | 101.03  | 33.11  | 87.66  | 
Payout (%)  | ||||
Dividend payout  | 0  | 0  | 0  | 0  | 
Tax payout  | -57.89  | -63.61  | -59.66  | 9.08  | 
Liquidity ratios  | ||||
Debtor days  | 103.71  | 145.59  | 141.5  | 92.56  | 
Inventory days  | 88.58  | 100.32  | 99.17  | 91.02  | 
Creditor days  | -100.62  | -99.73  | -103.51  | -55.61  | 
Leverage ratios  | ||||
Interest coverage  | -0.23  | 0.71  | 0.24  | 0.1  | 
Net debt / equity  | 0.46  | 0.7  | 1.24  | 0.93  | 
Net debt / op. profit  | 6.01  | -37.79  | 27.84  | 1,456.59  | 
Cost breakup (₹)  | ||||
Material costs  | -39.22  | -41.98  | -42.31  | -45.65  | 
Employee costs  | -23.18  | -28.17  | -26.13  | -23.8  | 
Other costs  | -28.35  | -32.16  | -27.36  | -30.49  | 
WCK 6777 is the only once-a-day antibiotic in the global pipeline designated for outpatient parenteral antimicrobial therapy (OPAT).
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.